Stocktoria

Compass Therapeutics, Inc. CMPX

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-11-13

Compass Therapeutics, Inc. statistics & valuation

Market cap$374.6M
P / B1.9×
Return on equity-33.8%
Return on capital-35.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
201920192020202020212022202320242025
Operating margin (%)
-6661.80% 201920192020202020212022202320242025
Return on equity (%)
-308.40% -73.90% -58.70% -21.60% -28.60% -39.40% -33.80% 201920192020202020212022202320242025
Shares outstanding
5.0M 7.0M 5.0M 51.2M 100.8M 126.3M 127.7M 137.8M 178.3M 201920192020202020212022202320242025
Net debt ($)
-$16.0M -$45.2M -$144.5M 201920192020202020212022202320242025
Share buybacks ($)
201920192020202020212022202320242025
Return on assets (%)
-740.60% -114.40% -1000.90% -56.80% -53.40% -19.60% -27.10% -35.20% -30.30% 201920192020202020212022202320242025
Free cash flow margin (%)
-5282.20% 201920192020202020212022202320242025
Debt / equity (×)
0.82× 0.05× 0.00× 201920192020202020212022202320242025
EPS ($)
201920192020202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2020FY2019FY2019
Operating margin—-6661.8%———————
Net margin—-5808.8%———————
FCF margin—-5282.2%———————
Return on assets-30.3%-35.2%-27.1%-19.6%-53.4%-56.8%-1000.9%-114.4%-740.6%
Return on equity-33.8%-39.4%-28.6%-21.6%-58.7%-73.9%0.0%-308.4%0.0%
Debt / equity————0.00×0.05×—0.82×—
Current ratio15.0214.9619.7312.0513.844.970.032.670.06

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.